BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12938676)

  • 1. Retrospective study of the safety of caspofungin in immunocompromised pediatric patients.
    Franklin JA; McCormick J; Flynn PM
    Pediatr Infect Dis J; 2003 Aug; 22(8):747-9. PubMed ID: 12938676
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination therapy with caspofungin and amphotericin B lipid complex.
    Lum LR; Turco TF; Leone J
    Am J Health Syst Pharm; 2002 Jan; 59(1):80-1. PubMed ID: 11813474
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety and tolerability of caspofungin acetate in the treatment of fungal infections.
    Sable CA; Nguyen BY; Chodakewitz JA; DiNubile MJ
    Transpl Infect Dis; 2002 Mar; 4(1):25-30. PubMed ID: 12123423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compassionate use study of caspofungin in children with proven or suspected invasive mycosis or persistent febrile neutropenia.
    Madero L; Sanchez de Toledo J; Castel V; Sevilla J; Gonzalez-Esteban J; Sanz-Rodriguez C
    J Chemother; 2009 Apr; 21(2):229-31. PubMed ID: 19423481
    [No Abstract]   [Full Text] [Related]  

  • 5. Caspofungin treatment in severely ill, immunocompromised patients: a case-documentation study of 118 patients.
    Glasmacher A; Cornely OA; Orlopp K; Reuter S; Blaschke S; Eichel M; Silling G; Simons B; Egerer G; Siemann M; Florek M; Schnitzler R; Ebeling P; Ritter J; Reinel H; Schütt P; Fischer H; Hahn C; Just-Nuebling G
    J Antimicrob Chemother; 2006 Jan; 57(1):127-34. PubMed ID: 16308418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caspofungin acetate: an antifungal agent.
    Hoang A
    Am J Health Syst Pharm; 2001 Jul; 58(13):1206-14; quiz 1215-7. PubMed ID: 11449878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspofungin: the first of a new class of antifungal agents.
    Valgus JM
    Cancer Pract; 2001; 9(6):314-6. PubMed ID: 11879335
    [No Abstract]   [Full Text] [Related]  

  • 8. New antifungal drugs and the pediatric cancer patient: current status of clinical development.
    Groll AH; Lehrnbecher T
    Klin Padiatr; 2005; 217(3):158-68. PubMed ID: 15858708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experiences with the use of caspofungin in paediatric patients.
    Lehrnbecher T; Groll AH
    Mycoses; 2008; 51 Suppl 1():58-64. PubMed ID: 18471162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with caspofungin in immunocompromised paediatric patients: a multicentre survey.
    Groll AH; Attarbaschi A; Schuster FR; Herzog N; Grigull L; Dworzak MN; Beutel K; Laws HJ; Lehrnbecher T
    J Antimicrob Chemother; 2006 Mar; 57(3):527-35. PubMed ID: 16431856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caspofungin acetate for treatment of invasive fungal infections.
    Pacetti SA; Gelone SP
    Ann Pharmacother; 2003 Jan; 37(1):90-8. PubMed ID: 12503942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of caspofungin therapy in children with invasive fungal infections.
    Merlin E; Galambrun C; Ribaud P; Blanc T; Michel G; Auvrignon A; Stéphan JL
    Pediatr Infect Dis J; 2006 Dec; 25(12):1186-8. PubMed ID: 17133169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caspofungin. L 743872, MK 0991, MK 991.
    Drugs R D; 1999 Feb; 1(2):165-7. PubMed ID: 10566014
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety experience with caspofungin in pediatric patients.
    Zaoutis T; Lehrnbecher T; Groll AH; Steinbach WJ; Jafri HS; Maertens J; Ngai AL; Chow JW; Taylor AF; Strohmaier KM; Bourque M; Bradshaw SK; Petrecz M; Kartsonis NA
    Pediatr Infect Dis J; 2009 Dec; 28(12):1132-5. PubMed ID: 19779392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trichosporon asahii infection treated with caspofungin combined with liposomal amphotericin B.
    Bassetti M; Bisio F; Di Biagio A; Pierri I; Balocco M; Soro O; Cruciani M; Bassetti D
    J Antimicrob Chemother; 2004 Aug; 54(2):575-7. PubMed ID: 15231763
    [No Abstract]   [Full Text] [Related]  

  • 16. Caspofungin for Candida endocarditis.
    Mrówczyński W; Wojtalik M
    Pediatr Infect Dis J; 2004 Apr; 23(4):376. PubMed ID: 15071306
    [No Abstract]   [Full Text] [Related]  

  • 17. Caspofungin: a major breakthrough in treatment of systemic fungal infections.
    Agarwal MB; Rathi SA; Ratho N; Subramanian R
    J Assoc Physicians India; 2006 Dec; 54():943-8. PubMed ID: 17334012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caspofungin.
    Chandrasekar PH; Manavathu EK
    Drugs Today (Barc); 2002 Dec; 38(12):829-46. PubMed ID: 12582472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caspofungin acetate, bivalirudin.
    Am J Health Syst Pharm; 2001 Oct; 58(19):1807-9. PubMed ID: 11596694
    [No Abstract]   [Full Text] [Related]  

  • 20. Advances in antifungal therapy.
    Pannaraj PS; Walsh TJ; Baker CJ
    Pediatr Infect Dis J; 2005 Oct; 24(10):921-2. PubMed ID: 16220093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.